Equity Overview
Price & Market Data
Price: $497.7
Daily Change: -$0.359 / 0.07%
Daily Range: $495.9 - $501.5
Market Cap: $13,987,236,864
Daily Volume: 46,919
Performance Metrics
1 Week: 1.79%
1 Month: 7.74%
3 Months: 58.44%
6 Months: 51.10%
1 Year: 35.31%
YTD: 50.36%
Company Details
Employees: 5900
Sector: Commercial services
Industry: Miscellaneous commercial services
Country:
Details
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.